Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) Shares Outstanding (Weighted Average) (2016 - 2025)

CV Sciences' Shares Outstanding (Weighted Average) history spans 14 years, with the latest figure at $184.3 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) rose 1.1% year-over-year to $184.3 million; the TTM value through Sep 2025 reached $184.3 million, up 1.1%, while the annual FY2022 figure was $138.0 million, 28.03% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2025 was $184.3 million at CV Sciences, roughly flat from $184.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $184.3 million in Q1 2025 and bottomed at $104.5 million in Q1 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $152.1 million (2023), against an average of $146.6 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) skyrocketed 36.82% in 2022 before it grew 1.1% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $107.8 million in 2021, then grew by 28.03% to $138.0 million in 2022, then grew by 10.92% to $153.1 million in 2023, then rose by 19.04% to $182.3 million in 2024, then grew by 1.1% to $184.3 million in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Shares Outstanding (Weighted Average) are $184.3 million (Q3 2025), $184.3 million (Q2 2025), and $184.3 million (Q1 2025).